| Date of diagnosis | 2024/3/20 |
| Donor ID | CL36366 |
| Date of Draw | 2024/8/20 |
| Processing | Double spin |
| Volume | 1.0 mL |
| Race | Caucasian |
| Concomitant Diseases | Ischemic heart disease, Essential hypertension, Heart failure stage II, Cerebrovascular disease |
| Height, cm | 163 |
| Weight, kg | 98 |
| Cancer History and Relapses | No |
| Note | |
| HIV, HBV, HCV, RPR | Negative |
| Location Country | Ukraine |
| MMSE | 11 |
| COVID-19 Vaccination | Vaccinated: Moderna, 1 dose |
| Smoking History | Non-smoker |
| Drinking History | Occasional drinker |
| Treatment | Medications: Donepezil 10 mg, per os, once a day, since 10-Aug-2024 |
| Lab Tests | CBC: 19-Aug-2024: RBC: 4.52*1012/L; HGB: 103 g/L; PLT: 491*109/L; WBC: 6.9*109/L; NEU: 78%; EOS: 1%; LYM: 9%; MON: 12%; ESR: 5 mm/hour. Biochemistry: 19-Aug-2024: Total protein: 66.9 g/L; Total bilirubin: 20.1 μmol/L; Direct bilirubin: 4.1 μmol/L; ALAT: 11.3 u/L; ASAT: 10 u/L; Creatinine: 55.36 μmol/L; Urea: 3.61 mmol/L; Glucose: 5.4 mmol/L; Total cholesterol: 4.8 mmol/L; HDL: 2.9 mmol/L; LDL: 1.2 mmol/L |
| Treatment of Concomitant Diseases | Medications: Enalapril 10 mg, per os, once a day, since 20-Mar-2024; Bisoprolol 5 mg, per os, once a day, since 20-Mar-2024 |
| Comments Data | "MMSE score: 11; Clinical symptoms: Impairment of memory, agnosia, movement coordination disorder, spatial and temporal disorientation, fine motor disability, emotional lability, delusion, intellectual impairment. Date of MRI: 18-Aug-2024; MRI Conclusion: Signs of degenerative and atrophic changes in the brain cortex. Cerebral microangiopathy, Fazekas III." |
